Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function

被引:0
|
作者
Giuntoli, RL
Lu, J
Kobayashi, H
Kennedy, R
Celis, E
机构
[1] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA
[3] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The survival and proliferation of CTL during the effector phase of the immune response is critical for the elimination of infectious agents and tumor cells. We report here that in an in vitro model system, the expansion and cytolytic function of tumor-reactive human CTL can be enhanced by CD4(+) helper T lymphocytes through costimulatory signals that are mediated by cell surface molecules. The results presented here suggest that costimulatory receptors on CTL such as CD27, CD134 (4-1BB), and MHC class 11 are capable of directly interacting with the corresponding ligands on T-helper lymphocytes resulting in enhanced proliferation and survival of the CTL during the effector phase of antitumor immune responses. These findings underline the importance of antigen-specific helper T lymphocytes for the regulation and maintenance of CTL immunity, and have implications for the design of therapeutic vaccines for cancer.
引用
收藏
页码:922 / 931
页数:10
相关论文
共 50 条
  • [21] Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
    Klebanoff, CA
    Gattinoni, L
    Torabi-Parizi, P
    Kerstann, K
    Cardones, AR
    Finkelstein, SE
    Palmer, DC
    Antony, PA
    Hwang, ST
    Rosenberg, SA
    Waldmann, TA
    Restifo, NP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (27) : 9571 - 9576
  • [22] Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells
    Peng, LM
    Shu, SY
    Krauss, JC
    CANCER RESEARCH, 1997, 57 (21) : 4849 - 4854
  • [23] Time to Akt: Superior tumor-reactive T cells for adoptive immunotherapy
    van der Waart, Anniek B.
    Hobo, Willemijn
    Dolstra, Harry
    ONCOIMMUNOLOGY, 2015, 4 (05):
  • [24] TARGETING SIRT2 RESCUES THE METABOLIC FITNESS AND EFFECTOR FUNCTIONS OF TUMOR-REACTIVE T CELLS WITHIN THE METABOLICALLY RESTRICTED TUMOR MICROENVIRONMENT
    Hamaidi, Imene
    Zhang, Lin
    Kim, Nayoung
    Wang, Min-Hsuan
    Iclozan, Cristina
    Fang, Bin
    Liu, Min
    Koomen, John
    Berglund, Anders
    Yoder, Sean
    Yao, Jiqiang
    Engelman, Robert
    Creelan, Ben
    Conejo-Garcia, Jose
    Antonia, Scott
    Mule, James
    Kim, Sungjune
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A59 - A59
  • [25] Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
    Kumai, Takumi
    Ishibashi, Kei
    Oikawa, Kensuke
    Matsuda, Yoshinari
    Aoki, Naoko
    Kimura, Shoji
    Hayashi, Satoshi
    Kitada, Masahiro
    Harabuchi, Yasuaki
    Celis, Esteban
    Kobayashi, Hiroya
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (05) : 469 - 478
  • [26] Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
    Takumi Kumai
    Kei Ishibashi
    Kensuke Oikawa
    Yoshinari Matsuda
    Naoko Aoki
    Shoji Kimura
    Satoshi Hayashi
    Masahiro Kitada
    Yasuaki Harabuchi
    Esteban Celis
    Hiroya Kobayashi
    Cancer Immunology, Immunotherapy, 2014, 63 : 469 - 478
  • [27] Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy
    Li, Q
    Carr, A
    Ito, F
    Teitz-Tennenbaum, S
    Chang, AE
    CANCER RESEARCH, 2003, 63 (10) : 2546 - 2552
  • [28] p53110-124-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells
    Chikamatsu, K
    Albers, A
    Stanson, J
    Kwok, WW
    Appella, E
    Whiteside, TL
    DeLeo, AB
    CANCER RESEARCH, 2003, 63 (13) : 3675 - 3681
  • [29] Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy
    Meraviglia, S.
    Caccamo, N.
    Guggino, G.
    Tolomeo, M.
    Siragusa, S.
    Stassi, G.
    Dieli, F.
    CURRENT MOLECULAR MEDICINE, 2010, 10 (08) : 719 - 726
  • [30] Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8+ T cells
    Redmond, William L.
    Linch, Stefanie N.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (10) : 2519 - 2522